Loss-of-function pathogenic variants in EPM2A or EPM2B lead to an accumulation of Lafora bodies (an abnormal form of glycogen that cannot be metabolized) and subsequent Lafora disease (47). The gene discussed is EPM2A; the disease is Lafora disease.